Skip to content
Search

Latest Stories

'Dwindling margins' are making pharmacies untenable

Lack of appropriate funding is making survival a massive challenge for community pharmacy, a sector relied upon as a vital support system by both primary and secondary care in England.

The Telegraph newspaper ran a story on Monday (August 22) which highlighted the dire straits community pharmacy finds itself in. Seasoned pharmacist Ian Strachan told the paper: “Our four pharmacies were the only point of call that was open (during Covid). We were there every single day, even when the virus was prevalent and people were dying.”


Describing the current situation, he said: “What is happening is we're facing a system that's just not working at all in our favour.” Strachan says the issue is that pharmacists are “just not getting the help we need to be able to do this job properly”.

The sector is hugely dependent on funding from the NHS. The government had agreed in 2019 to set £2.6bn as annual funding for the sector. However, according to a report from EY that amount was already down £200m on the 2016 levels of government funding.

“We've been starved of appropriate funding since 2016,” Dr Leyla Hannbeck, chief executive of the Association of Independent Multiple Pharmacies told The Telegraph. “It looks grim for businesses. The fees pharmacists get are going nowhere, but now, there’s higher utility bills, higher staff fees and higher drug costs.”

The paper cited another challenge faced by Paul Mason, a superintendent pharmacist at the Yorkshire pharmacy group Lo’s Pharmacy. Mason said he was looking for one item yesterday “and the cheapest price” he could get the stock for was at least "20 times what the NHS drug tariff was listing”.

“If I’d bought it, I’d be losing £20 a box on that one. It’s just not reasonable."

Mason stated that with such “dwindling margins it is difficult to reward our staff appropriately in the current environment".

“It is heartbreaking for me,” Hannbeck told The Telegraph. “I’m hearing members say that they have put everything into their pharmacy to make sure that they’re providing healthcare in communities, particularly in areas of high deprivation, and then they're in a position where they have to sell their house to survive.”

On the funding situation, The Telegraph also quoted Boots pharmacy director Anne Higgins as saying, “is not sustainable in the long term and, like the rest of the sector, we want to work with the government to address this”.

Data from the PSNC shows that over 639 local pharmacies have been lost in England since 2016. In July, two dozen parliamentarians from across the political spectrum called on the prime minister to act as a wave of pharmacy closures in recent years has threatened to spiral out of control.

A letter to the prime minister signed by 24 MPs and peers has warned that worse could be yet to come after “spiralling business costs” and “year after year of real terms funding cuts” have led to hundreds of pharmacy closures.

“Because the thing is, all the obvious costs have gone up,” told Gareth Jones, the NPA’s director of corporate affairs to the Telegraph. “There are all those same costs you'd expect any business to have to shoulder and there is no ability to increase prices, to respond to this sort of situation, because of the way the sector is heavily reliant on NHS funding from the government.”

“We can be the solution for the NHS,” Hannbeck told The Telegraph. “We can provide those services to cut the number of people going to A&E”. But, in her view, “you can’t just add these extra things on and not pay. We just can't be treated like that."

According to the EY report, the situation might worsen as data suggested in 2020 that 60 per cent of pharmacies would be loss-making by 2021, which may rise even further, to 72 per cent by 2024.

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less